Evidence map›Paper›PMID 30305475›Full record

ArticleJournal of clinical and experimental hematopathology : JCEH2018

Cladribine treatment for Erdheim-Chester disease involving the central nervous system and concomitant polycythemia vera: A case report.

Suguru Tamura, Keisuke Kawamoto, Hiroaki Miyoshi, Takaharu Suzuki, Takayuki Katagiri, Takuya Kasami, Hiroki Nemoto, Shukuko Miyakoshi, Hironori Kobayashi, Yasuhiko Shibasaki and 5 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical and experimental hematopathology : JCEH, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Suguru Tamura
Keisuke Kawamoto
Hiroaki Miyoshi
Takaharu Suzuki
Takayuki Katagiri
Takuya Kasami
Hiroki Nemoto
Shukuko Miyakoshi
Hironori Kobayashi
Yasuhiko Shibasaki
Masayoshi Masuko
Kengo Takeuchi
Koichi Ohshima
Hirohito Sone
Jun Takizawa
Kurume University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Erdheim-Chester disease (ECD), a rare form of non-Langerhans cell histiocytosis, is characterized by the infiltration of foamy CD68

Indexed as

Central Nervous System DiseasesErdheim-Chester DiseaseJanus Kinase 2Mutation, MissensePolycythemia VeraProto-Oncogene Proteins B-rafAgedAmino Acid SubstitutionCladribineHumansMaleBRAF protein, humanCladribineJAK2 protein, humanJanus Kinase 2Proto-Oncogene Proteins B-rafBRAFcladribineErdheim–Chester diseaseJAK2polycythemia vera

Identifiers

PMID30305475
PMCPMC6407475
OpenAlexW2897321765

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.